Berko İlaç's Phase III Investment Wins Award

The ninth edition of the "Golden Mortar Awards 2018" saw Berko İlaç earn the "Production Facility Investment Award" for its Phase III Manufacturing Facilities investment. The ceremony, organized by Eczacı Dergisi, was attended by representatives from the pharmaceutical sector, civil society organizations, independent pharmacists and pharmacy students. Eylem Beran, Member of the Board of Directors and Corporate Communications Director of Berko İlaç, received the award on behalf of the company. Eylem Beran stated: "We thank the esteemed jury members and the Novi Medya family for deeming us worthy of this award. I wish our new investment to be auspicious for our country." With the commissioning of the third phase of the manufacturing facilities, Berko İlaç now has 21,000 square meters of enclosed space and an annual production capacity of 142 million boxes. Berko İlaç, which holds an important position in the Turkish pharmaceutical market, exports to 16 countries, primarily the United States and Canada, with a vision of becoming a global brand. With over 700 employees producing and working for health, Berko İlaç's goal is to increase production, employment and exports with the new phase brought into service.